Connor, Clark & Lunn Investment Management Ltd. Ptc Therapeutics, Inc. Transaction History

Connor, Clark & Lunn Investment Management Ltd.

$20 Billion
Q4 2024

A detailed history of Connor, Clark & Lunn Investment Management Ltd. transactions in Ptc Therapeutics, Inc. stock. As of the latest transaction made, Connor, Clark & Lunn Investment Management Ltd. holds 23,632 shares of PTCT stock, worth $1.14 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

23,632

Previous 38,910 39.26%

Holding current value

$1.14 Million

Previous $1.44 Million 26.13%

% of portfolio

0.01%

Previous 0.01%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 10, 2025	SELL	$34.99 - $52.07 $534,577 - $795,525	-15,278 Reduced 39.26%	23,632 $1.07 Million
Q3 2024 Nov 08, 2024	SELL	$30.39 - $37.66 $475,877 - $589,717	-15,659 Reduced 28.7%	38,910 $1.44 Million
Q2 2024 Aug 09, 2024	BUY	$24.69 - $40.12 $1.35 Million - $2.19 Million	54,569 New	54,569 $1.67 Million
Q4 2022 Feb 10, 2023	SELL	$33.53 - $54.79 $313,036 - $511,519	-9,336 Reduced 12.34%	66,347 $2.53 Million
Q3 2022 Nov 10, 2022	BUY	$41.85 - $53.85 $2.75 Million - $3.53 Million	65,600 Added 650.6%	75,683 $3.8 Million
Q2 2022 Aug 05, 2022	BUY	$25.6 - $45.23 $258,124 - $456,054	10,083 New	10,083 $404,000
Q1 2021 May 13, 2021	SELL	$46.8 - $68.92 $187,714 - $276,438	-4,011 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$47.96 - $67.64 $192,367 - $271,304	4,011 New	4,011 $245,000
Q3 2019 Nov 13, 2019	SELL	$33.82 - $48.17 $673,254 - $958,920	-19,907 Closed	0 $0
Q2 2019 Aug 07, 2019	SELL	$35.42 - $45.0 $868,108 - $1.1 Million	-24,509 Reduced 55.18%	19,907 $896,000
Q1 2019 May 08, 2019	SELL	$28.09 - $39.49 $1.81 Million - $2.55 Million	-64,574 Reduced 59.25%	44,416 $1.67 Million
Q4 2018 Feb 12, 2019	SELL	$29.83 - $46.51 $1.05 Million - $1.64 Million	-35,347 Reduced 24.49%	108,990 $3.74 Million
Q3 2018 Nov 13, 2018	SELL	$33.9 - $47.77 $4.43 Million - $6.24 Million	-130,585 Reduced 47.5%	144,337 $6.78 Million
Q2 2018 Aug 02, 2018	SELL	$25.7 - $47.88 $6.27 Million - $11.7 Million	-244,156 Reduced 47.04%	274,922 $9.27 Million
Q1 2018 May 14, 2018	BUY	$17.46 - $32.59 $230,035 - $429,373	13,175 Added 2.6%	519,078 $14 Million
Q4 2017 Feb 09, 2018	BUY	$15.14 - $20.89 $1.17 Million - $1.61 Million	76,978 Added 17.95%	505,903 $8.44 Million
Q3 2017 Nov 14, 2017	BUY	$16.81 - $21.61 $6.6 Million - $8.49 Million	392,850 Added 1088.98%	428,925 $8.58 Million
Q2 2017 Aug 14, 2017	BUY	N/A	36,075	36,075 $661,000

Others Institutions Holding PTCT

# of Institutions

262

Shares Held

72.6M

Call Options Held

179K

Put Options Held

536K

View Full List

About PTC THERAPEUTICS, INC.

Ticker PTCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,541,000
Market Cap $3.45B
Description
PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...

More about PTCT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Connor, Clark & Lunn Investment Management Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Connor, Clark & Lunn Investment Management Ltd. with notifications on news.

Account

Connor, Clark & Lunn Investment Management Ltd. Ptc Therapeutics, Inc. Transaction History